It is also of note that AC-480 exhibited increased cell line-dependent synergistic or additive apoptosis in head and neck squamous cell carcinomas when used as a co-inhibitor with the insulin-like growth factor-1 receptor 1 (IGF1R) inhibitor, BMS-754807 [69]. Here, IGF1R is linked to head and neck squamous cell carcinoma.